CLINICAL_TRIALS
trial_result
· 2015-09-07
Clinical Trial Update: F901318 Single Ascending Dose Study in Healthy Male Volunteers [Phase 1]
Summary
Phase 1 single ascending dose study of F901318 in healthy male volunteers; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: F2G Biotech GmbH | Conditions: Invasive Aspergillosis | Phase 1 | Status: COMPLETED | Results posted: 2015-09-07